|
Printable version |
From: | "G Stolwyk" <stolwyk@wave.co.nz> |
Date: | Wed, 20 Nov 2002 10:27:08 +1300 |
As mentioned before, these trials have 2
parts:
1. Phenoxodiol drug stand alone (completion before
Dec31) and
2. Mixed with another drug (cocktail). I am
particularly interested in this one which is to start in January after the
completion of item1. This is to finish about June, next year.
The first one concerns Phenoxodiol by
intravenous injection. A number of Leukemias and some other diseases are
involved. The work is to be done at RNS Hospital in Sydney and various cliniques
in the US.
We had hoped that the Australian trials would have
started 6 weeks ago but due to logistics problems, it is to start
today.
Yale university will be in charge of these trials.
Phenoxodiol did a wonderful job in the lab; it killed cancers within 2
days. Novogen expects that when used on humans it would kill within a week, that
is, if it is successful. The world's top brains have done the research on
it.
We ought to get reports at end of Dec or in Jan., I
think.
Gerry
This NRT opens up a new world, much to learn about
medical terms, interesting and rewarding, I
hope!
|
|